10 Jun 2013 12:18
10 June 2013
Omega Diagnostics Group PLC
(the "Company")
Result of General Meeting
Omega Diagnostics Group PLC (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that at a general meeting of its shareholders held today, all resolutions proposed were duly passed.
Accordingly, the Company confirms that it has completed the placing and subscription of 23,529,412 new ordinary shares of 4 pence each in the capital of the Company (the "New Ordinary Shares") with new and existing shareholders at a price of 17 pence per New Ordinary Share.
The New Ordinary Shares are expected to be admitted to trading on AIM ("Admission") tomorrow and the total number of issued ordinary shares following Admission will be 108,745,669.
The details of the Directors' holdings following Admission are set out in the table below.
Director | Number of ordinary shares following Admission | Percentage of ordinary shares in issue following Admission
|
David Evans | 2,870,134 | 2.64 |
Andrew Shepherd | 2,659,206 | 2.45 |
Jag Grewal | 29,412 | 0.03 |
Kieron Harbinson | 323,562 | 0.30 |
Michael Gurner | 418,730 | 0.39 |
William Rhodes | - | - |
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
Jag Grewal, Group Sales and Marketing Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Christopher Raggett (Corporate Finance) | |
Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul Cornelius | Mob: 07866 384 707 |
Lianne Cawthorne | Mob: 07584 391 303 |